martes, 19 de noviembre de 2019

Biotech venture capitalists speak out against Pelosi’s drug pricing bill

Biotech venture capitalists speak out against Pelosi’s drug pricing bill

Daily Recap

STAT Plus: In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill

By NICHOLAS FLORKO


BRENDAN SMIALOWSKI/AFP VIA GETTY IMAGES
Venture capitalists have typically avoided the political fray, but several are speaking out against Democrats’ drug pricing bill.

No hay comentarios: